SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-23-008866
Filing Date
2023-03-24
Accepted
2023-03-24 16:10:56
Documents
8
Effectiveness Date
2023-03-24

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 64865
2 ex5-1.htm EX-5.1 22128
3 ex23-1.htm EX-23.1 4719
4 ex107.htm EX-FILING FEES 14123
5 ex5-1_001.jpg GRAPHIC 9158
6 ex5-1_002.jpg GRAPHIC 6323
7 ex23-1_001.jpg GRAPHIC 5209
8 ex23-1_002.jpg GRAPHIC 6506
  Complete submission text file 0001493152-23-008866.txt   144871
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270828 | Film No.: 23759969
SIC: 2834 Pharmaceutical Preparations